Then, PNA-PCR clamping and Sanger sequencing were used to blind test 90 DNA from 57 MDS and 33 MPN patients for the SF3B1 p.Lys700Glu mutation. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.